Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform.
about
Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinomaA novel, non-immunogenic Fyn SH3-derived binding protein with tumor vascular targeting propertiesIn vivo imaging of tumors with protease-activated near-infrared fluorescent probesSpecific and covalent labeling of a membrane protein with organic fluorochromes and quantum dotsDisruption of anthrax toxin binding with the use of human antibodies and competitive inhibitors.Isolation of anti-angiogenesis antibodies from a large combinatorial repertoire by colony filter screening.Identification of a glioblastoma-associated tenascin-C isoform by a high affinity recombinant antibodyInhibition of glial scarring in the injured rat brain by a recombinant human monoclonal antibody to transforming growth factor-beta2.Biological libraries.Peptides selected for binding to clotted plasma accumulate in tumor stroma and wounds.Selection of phage-displayed peptides on live adherent cells in microfluidic channels.NIR spectroscopic detection of breast cancer.Single-chain variable fragment antibodies against the neural adhesion molecule CHL1 (close homolog of L1) enhance neurite outgrowth.Single-chain antibody and its derivatives directed against vascular endothelial growth factor: application for antiangiogenic gene therapy.Design and use of a phage display library. Human antibodies with subnanomolar affinity against a marker of angiogenesis eluted from a two-dimensional gel.Whole-body optical imaging of green fluorescent protein-expressing tumors and metastasesIsolation of a colon tumor specific binding peptide using phage display selection.A novel assay for monitoring internalization of nanocarrier coupled antibodies.Panning and identification of a colon tumor binding peptide from a phage display peptide library.Identification of accessible human cancer biomarkers using ex vivo chemical proteomic strategies.A time domain fluorescence tomography system for small animal imaging.The POM monoclonals: a comprehensive set of antibodies to non-overlapping prion protein epitopes.The use of biosensor technology for the engineering of antibodies and enzymes.Peptide targeted tripod macrocyclic Gd(III) chelates for cancer molecular MRI.Molecular MRI of liver fibrosis by a peptide-targeted contrast agent in an experimental mouse model.MRI of breast tumor initiating cells using the extra domain-B of fibronectin targeting nanoparticles.Peptide-targeted Nanoglobular Gd-DOTA monoamide conjugates for magnetic resonance cancer molecular imagingStrategies to adapt adenoviral vectors for targeted delivery.Screening of peptides bound to breast cancer stem cell specific surface marker CD44 by phage display.Antibody phage display libraries: contributions to oncology.Challenges for imaging angiogenesis.Synthesis and spectroscopy of near infrared fluorescent dyes for investigating dichromic fluorescence.Molecular imaging in cancer treatment.ECM remodeling regulates angiogenesis: endothelial integrins look for new ligands.The multicompartmental p32/gClqR as a new target for antibody-based tumor targeting strategiesThe significance of immunohistochemistry in the diagnosis and therapy of neoplasms.In vivo imaging of metastatic cancer with fluorescent proteins.Cellular activation of the self-quenched fluorescent reporter probe in tumor microenvironment.The antitumor activity of tumor-homing peptide-modified thermosensitive liposomes containing doxorubicin on MCF-7/ADR: in vitro and in vivo.Fluorinated COX-2 inhibitors as agents in PET imaging of inflammation and cancer.
P2860
Q21144653-94B278E8-EA08-4992-91C6-780AB303834AQ24320137-C186D7B9-C337-4097-9C72-3C6D5A47C446Q28141852-ADB50731-FFB8-468F-AD01-6DFF86A58662Q30480043-8336988A-1A7D-4F05-A79F-12D59880C18BQ30638627-297A5613-B6A3-4998-B29F-4AA8975DE20AQ30655755-9A577807-EA89-437C-82F0-3E14DD93936FQ30700459-36543D18-FECE-4C71-85CA-ACCF4BE93434Q30724603-97C63DAE-2236-4D47-847A-EEA503CBF407Q30796540-9B1C885E-4C49-4D1D-824C-F56414A64403Q30807745-BC4ECECC-FB23-434D-866E-A864CF670D79Q31004986-117F0629-9440-416B-BE69-9BC512D9A62DQ31005913-3D4C7B9C-AA6D-425A-9267-70F0C5AA41B0Q31108009-A6FD7A4E-2810-4DE3-9672-991C4D7BE255Q31156150-12F9A1F1-25B5-4537-8F38-885C8E6B22E2Q32038879-71DC2148-3691-4A74-9017-1D39C308F78FQ33179635-01BDABD0-207B-4C43-B009-8DFEDEE73C7BQ33195846-F1839997-6708-4187-B138-96207A9E6F68Q33259109-23965256-AE3F-40EA-A8CD-1DA63F97D697Q33276355-F2BF9D09-B000-4FC6-AC25-8620EDE02329Q33309341-C6454315-A1A5-4CD4-B0EC-BB905173D415Q33356866-72D2B255-36C2-4251-B0FB-683B13EABF8AQ33390385-47E935E2-AFFA-42AE-B22E-4C4B8CE0593CQ33682947-AF181668-F78E-4A05-A9DE-054BB7B81F5BQ33768695-7F67C680-7590-44AD-9278-1556873F675FQ33768700-3BEA94D2-1337-4C58-A3DC-636F4F1D9597Q33779847-6B47F58F-1938-4ECB-9EEB-4B2F49B7FDB8Q33782280-79E96D1A-DA50-46A9-8558-580ADCA28A46Q33833388-4B6922A0-6D58-4769-ACDE-DF053AC40485Q34042492-92A3F881-4EBD-475B-BC16-F1DABB2EBB06Q34323991-BF75E7C9-102F-47E8-B632-11431037543AQ34417138-FA83FB87-D8D3-4AB8-B49F-449F93DC930EQ34440751-1A993E5C-9CFA-49C1-A3BE-61FB45713AE6Q34496670-4B9E808B-F61F-4279-A009-3F29357417C7Q34528233-7485427A-E042-4F95-B35E-24FFFDCE01ABQ34568373-EF427584-948A-445D-B536-BC3F53D7A51DQ34602545-0DE4CBA5-32A0-4D94-9FF5-1F46AE26C81DQ34728341-654983AA-F346-4C3A-8333-EB618B214042Q34929009-211FCFCF-A79E-4601-AE3C-B6D2778A3F6DQ35212787-3FB9C804-726A-47F4-8463-C8BB473D6A94Q35545603-5241C60A-D803-47C8-BC4B-E308896A17B2
P2860
Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Targeting by affinity-matured ...... ssociated fibronectin isoform.
@en
type
label
Targeting by affinity-matured ...... ssociated fibronectin isoform.
@en
prefLabel
Targeting by affinity-matured ...... ssociated fibronectin isoform.
@en
P2093
P2860
P356
P1433
P1476
Targeting by affinity-matured ...... ssociated fibronectin isoform.
@en
P2093
Carnemolla B
P2860
P2888
P304
P356
10.1038/NBT1197-1271
P577
1997-11-01T00:00:00Z
P6179
1019584452